GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhejiang East-Asia Pharmaceutical Co Ltd (SHSE:605177) » Definitions » Days Payable

Zhejiang East-Asia Pharmaceutical Co (SHSE:605177) Days Payable : 173.37 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Zhejiang East-Asia Pharmaceutical Co Days Payable?

Zhejiang East-Asia Pharmaceutical Co's average Accounts Payable for the three months ended in Mar. 2024 was ¥500 Mil. Zhejiang East-Asia Pharmaceutical Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥263 Mil. Hence, Zhejiang East-Asia Pharmaceutical Co's Days Payable for the three months ended in Mar. 2024 was 173.37.

The historical rank and industry rank for Zhejiang East-Asia Pharmaceutical Co's Days Payable or its related term are showing as below:

SHSE:605177' s Days Payable Range Over the Past 10 Years
Min: 100.4   Med: 150.83   Max: 240.69
Current: 176.4

During the past 8 years, Zhejiang East-Asia Pharmaceutical Co's highest Days Payable was 240.69. The lowest was 100.40. And the median was 150.83.

SHSE:605177's Days Payable is ranked better than
55.48% of 721 companies
in the Biotechnology industry
Industry Median: 148.78 vs SHSE:605177: 176.40

Zhejiang East-Asia Pharmaceutical Co's Days Payable increased from Mar. 2023 (126.67) to Mar. 2024 (173.37). It may suggest that Zhejiang East-Asia Pharmaceutical Co delayed paying its suppliers.


Zhejiang East-Asia Pharmaceutical Co Days Payable Historical Data

The historical data trend for Zhejiang East-Asia Pharmaceutical Co's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang East-Asia Pharmaceutical Co Days Payable Chart

Zhejiang East-Asia Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial 100.40 138.47 240.69 163.84 170.78

Zhejiang East-Asia Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 126.67 170.24 188.98 186.43 173.37

Competitive Comparison of Zhejiang East-Asia Pharmaceutical Co's Days Payable

For the Biotechnology subindustry, Zhejiang East-Asia Pharmaceutical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang East-Asia Pharmaceutical Co's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zhejiang East-Asia Pharmaceutical Co's Days Payable distribution charts can be found below:

* The bar in red indicates where Zhejiang East-Asia Pharmaceutical Co's Days Payable falls into.



Zhejiang East-Asia Pharmaceutical Co Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Zhejiang East-Asia Pharmaceutical Co's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (411.088 + 520.118) / 2 ) / 995.092*365
=465.603 / 995.092*365
=170.78

Zhejiang East-Asia Pharmaceutical Co's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

Days Payable (Q: Mar. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2023 ) + Accounts Payable (Q: Mar. 2024 )) / count ) / Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=( (520.118 + 479.34) / 2 ) / 263.023*365 / 4
=499.729 / 263.023*365 / 4
=173.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang East-Asia Pharmaceutical Co Days Payable Related Terms

Thank you for viewing the detailed overview of Zhejiang East-Asia Pharmaceutical Co's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang East-Asia Pharmaceutical Co (SHSE:605177) Business Description

Traded in Other Exchanges
N/A
Address
Laodong North Road, 23rd Floor, General Chamber of Commerce Building, Huangyan District, Zhejiang Province, Taizhou, CHN
Zhejiang East-Asia Pharmaceutical Co Ltd is mainly engaged in the production of bulk pharmaceutical chemicals, tablets, granules and capsules. The company's main products are: Ofloxacin, levofloxacin, loratadine hydrochloride, levofloxacin hydrochloride, trimebutine maleate, ketoconazole, terbinafine hydrochloride, piperazine, ticlazole and so on.

Zhejiang East-Asia Pharmaceutical Co (SHSE:605177) Headlines

No Headlines